Danaher Corporation (DHR): Price and Financial Metrics


Danaher Corporation (DHR)

Today's Latest Price: $166.87 USD

1.49 (0.90%)

Updated Jun 2 3:57pm

Add DHR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 59 in Industrial - Machinery

See all "A" rated Strong Buy stocks

DHR Stock Summary

  • Danaher Corp's market capitalization of $115,354,399,775 is ahead of 98.57% of US-listed equities.
  • With a year-over-year growth in debt of 173.53%, Danaher Corp's debt growth rate surpasses 91.24% of about US stocks.
  • In terms of volatility of its share price, DHR is more volatile than just 3.82% of stocks we're observing.
  • Stocks that are quantitatively similar to DHR, based on their financial statements, market capitalization, and price volatility, are IBM, GSK, CHTR, WFC, and TMUS.
  • Visit DHR's SEC page to see the company's official filings. To visit the company's web site, go to www.danaher.com.
DHR Daily Price Range
DHR 52-Week Price Range

DHR Stock Price Chart More Charts


DHR Price/Volume Stats

Current price $166.87 52-week high $170.64
Prev. close $165.38 52-week low $119.60
Day low $164.31 Volume 2,352,531
Day high $166.90 Avg. volume 3,475,305
50-day MA $153.78 Dividend yield 0.44%
200-day MA $148.41 Market Cap 116.39B

Danaher Corporation (DHR) Company Bio


Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company was founded in 1969 and is based in Washington, the District of Columbia.

DHR Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$166.87$53.43-68%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Danaher Corp. To summarize, we found that Danaher Corp ranked in the 21th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Danaher Corp ended up being:

  • DHR's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 28.47% of tickers in our DCF set.
  • The weighted average cost of capital for the company is 7. This value is greater than only 14.15% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-69%
1%-68%
2%-68%
3%-68%
4%-67%
5%-67%

BAX, ELMD, MTD, PBYI, and NRC can be thought of as valuation peers to DHR, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


DHR Latest News Stream


Event/TimeNews Detail
Loading, please wait...

DHR Latest Social Stream


Loading social stream, please wait...

View Full DHR Social Stream

Latest DHR News From Around the Web

Below are the latest news stories about Danaher Corp that investors may wish to consider to help them evaluate DHR as an investment opportunity.

How This Week Highlights the Challenges Facing General Electric Stock

I've been a skeptic toward General Electric (NYSE:GE) stock for some time now. Truthfully, I'm not too happy about it.Source: Sundry Photography / Shutterstock.com After all, General Electric once was one of America's greatest and most innovative companies. It provided thousands of employees with stable jobs and generous retirement plans. GE stock was a core holding of pension funds and individual investors.Sadly, that's no longer the case. General Electric offers many fewer jobs: its workforce shrunk 28% worldwide in 2019. And GE stock, almost incredibly, touched a 29-year low this month. Its dividend has been cut -- twice.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe reality is sad. But it's still the reality. Investors need to react accordingly. * 7 Red-Hot Vacci...

Yahoo | May 29, 2020

FDA Lists Beckman Coulter Life Sciences RNA Extraction Kit For Use In EUA-Authorized COVID-19 Test

Beckman Coulter Life Sciences today announced RNAdvance Viral XP has been added to the list of acceptable extraction methods for use in the Centers for Disease Control's EUA-authorized COVID-19 test referenced in the FDA's FAQ on testing for SARS-CoV-2. Laboratories are now permitted to independently validate RNAdvance Viral XP for use.

Yahoo | May 28, 2020

Hedge Funds Have Never Been This Bullish On Danaher Corporation (DHR)

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]

Yahoo | May 26, 2020

Danaher Luxembourg Finance S.a.r.l. -- Moody's announces completion of a periodic review of ratings of Danaher Corporation

Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Danaher Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

Yahoo | May 19, 2020

Beckman Coulter launches DxH 690T mid-volume hematology analyzer, featuring the Early Sepsis Indicator in U.S. market

Beckman Coulter announced today the availability of its DxH 690T hematology analyzer in the U.S. Designed to streamline workflow and minimize downtime in mid-volume laboratories, the DxH 690T delivers all of the benefits of the company's flagship DxH 900 large-volume hematology analyzer in a table-top configuration.

Yahoo | May 18, 2020

Read More 'DHR' Stories Here

DHR Price Returns

1-mo 3.79%
3-mo 7.13%
6-mo 13.65%
1-year 27.11%
3-year 95.52%
5-year 100.44%
YTD 8.88%
2019 49.55%
2018 11.80%
2017 20.01%
2016 -15.65%
2015 9.04%

DHR Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full DHR Dividend History

Continue Researching DHR

Want to see what other sources are saying about Danaher Corp's financials and stock price? Try the links below:

Danaher Corp (DHR) Stock Price | Nasdaq
Danaher Corp (DHR) Stock Quote, History and News - Yahoo Finance
Danaher Corp (DHR) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8922 seconds.